Nature Communications (Aug 2021)

How the glucocorticoid receptor contributes to platinum-based therapy resistance in solid cancer

  • Dorien Clarisse,
  • Karolien De Bosscher

DOI
https://doi.org/10.1038/s41467-021-24847-6
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 3

Abstract

Read online

Synthetic glucocorticoids serve as co-medication against solid malignant tumors. However, glucocorticoid receptor activation may promote unsolicited cancer resistance to chemotherapy. The Kang team elucidated a glucocorticoid receptor-centred chemotherapy-resistance mechanism to cisplatin and characterized avenues towards a viable escape strategy.